“…However, eight of the studies (35, 36, 38, 41-44, 51) did not report the assessment tool for the measurement of AUD. Regarding the setting of anti-tuberculosis treatment, seven (11,17,33,46,47,49,50), thirteen (14, 25, 35, 38-42, 44, 45, 48, 53) and another seven (34,36,43,51,52,54) of the included studies involved subjects with treatment setting at the primary health care setting (PHCU), hospital and both hospital and PHCU respectively. Also, twenty (14, 33, 35, 37-39, 44-47, 50, 52-54), four (17,25,43,48) and three (34,36,51) of the studies involved participant patients at the directly observed treatment(DOT), continuation and both phases of ant-tuberculosis treatment in the respective order (Table 1).…”